| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.735 | 0.002 | 0.735 | Neuronal nicotinic receptor antagonist | 0.063 0.051 CID_154699943 | ||
| 0.731 | 0.003 | 0.731 | Acetylcholine nicotinic antagonist | 0.084 0.051 CID_154699943 | ||
| 0.693 | 0.002 | 0.693 | Nicotinic receptor alpha7 subunit antagonist | 0.06 0.029 CID_154699943 | ||
| 0.65 | 0.002 | 0.65 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.659 | 0.018 | 0.659 | Analgesic | 0.343 0.112 CID_154699943 | ||
| 0.572 | 0.003 | 0.572 | Acetylcholine nicotinic agonist | |||
| 0.559 | 0.004 | 0.559 | Cholinergic antagonist | 0.361 0.01 CID_154699943 | ||
| 0.557 | 0.004 | 0.557 | Acetylcholine antagonist | 0.318 0.012 CID_154699943 | ||
| 0.535 | 0.003 | 0.535 | Acetylcholine agonist | |||
| 0.54 | 0.008 | 0.543 | Psychostimulant | 0.543 0.008 CID_154699943 | CID_154699943 | |
| 0.536 | 0.015 | 0.536 | Nootropic | |||
| 0.537 | 0.022 | 0.537 | 5 Hydroxytryptamine release stimulant | |||
| 0.529 | 0.023 | 0.601 | Vasodilator, peripheral | 0.601 0.016 CID_154699943 | CID_154699943 | |
| 0.495 | 0.01 | 0.495 | Sigma receptor agonist | 0.158 0.08 CID_154699943 | ||
| 0.483 | 0.002 | 0.483 | Nicotinic neuronal receptor agonist | |||
| 0.478 | 0.017 | 0.478 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.476 | 0.018 | 0.476 | HERG channel blocker | |||
| 0.431 | 0.003 | 0.431 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.473 | 0.047 | 0.473 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.449 | 0.031 | 0.54 | Spasmolytic | 0.54 0.019 CID_154699943 | CID_154699943 | |
| 0.457 | 0.047 | 0.457 | Histamine release inhibitor | 0.382 0.085 CID_154699943 | ||
| 0.387 | 0.005 | 0.387 | Dopamine agonist | 0.07 0.044 CID_154699943 | ||
| 0.386 | 0.009 | 0.386 | NOS3 expression enhancer | 0.297 0.018 CID_154699943 | ||
| 0.382 | 0.006 | 0.394 | Acetylcholine M1 receptor antagonist | 0.394 0.005 CID_154699943 | CID_154699943 | |
| 0.377 | 0.003 | 0.377 | Nicotinic alpha7 receptor agonist | |||
| 0.369 | 0.002 | 0.369 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.372 | 0.006 | 0.372 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.362 | 0.003 | 0.362 | Nicotinic receptor alpha4 subunit antagonist | 0.079 0.013 CID_154699943 | ||
| 0.409 | 0.053 | 0.409 | MAP kinase kinase 6 inhibitor | 0.266 0.17 CID_154699943 | ||
| 0.381 | 0.026 | 0.381 | Potassium channel blocker | |||
| 0.366 | 0.021 | 0.366 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.346 | 0.005 | 0.346 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.354 | 0.013 | 0.354 | Cholinergic | |||
| 0.37 | 0.038 | 0.37 | Calcium channel activator | 0.299 0.093 CID_154699943 | ||
| 0.329 | 0.004 | 0.329 | Acetylcholine M4 receptor antagonist | |||
| 0.315 | 0.004 | 0.315 | Acetylcholine muscarinic agonist | |||
| 0.378 | 0.071 | 0.378 | GABA C receptor rho-3 antagonist | |||
| 0.303 | 0.004 | 0.303 | CYP2A6 inhibitor | |||
| 0.332 | 0.051 | 0.411 | Hypoxia-inducible factor 1 alpha inhibitor | 0.411 0.027 CID_154699943 | CID_154699943 | |
| 0.279 | 0.001 | 0.279 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.284 | 0.006 | 0.284 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.275 | 0.001 | 0.275 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.276 | 0.004 | 0.276 | Acetylcholine M1 receptor agonist | |||
| 0.287 | 0.015 | 0.287 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.3 | 0.042 | 0.533 | Cyclic AMP phosphodiesterase inhibitor | 0.533 0.005 CID_154699943 | CID_154699943 | |
| 0.263 | 0.006 | 0.263 | Opioid kappa receptor antagonist | 0.09 0.046 CID_154699943 | ||
| 0.26 | 0.004 | 0.26 | Prolactin inhibitor | |||
| 0.29 | 0.038 | 0.29 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.287 | 0.036 | 0.287 | Anesthetic general | 0.138 0.128 CID_154699943 | ||
| 0.259 | 0.014 | 0.259 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.26 | 0.019 | 0.26 | Activin receptor-like kinase 2 inhibitor | |||
| 0.253 | 0.014 | 0.253 | Acetylcholine muscarinic antagonist | 0.25 0.014 CID_154699943 | ||
| 0.239 | 0.001 | 0.239 | Nicotinic alpha4 receptor agonist | |||
| 0.291 | 0.054 | 0.291 | Superoxide dismutase inhibitor | |||
| 0.24 | 0.006 | 0.24 | 5 Hydroxytryptamine 3A agonist | |||
| 0.298 | 0.066 | 0.298 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.201 0.156 CID_154699943 | ||
| 0.255 | 0.024 | 0.255 | 5 Hydroxytryptamine antagonist | |||
| 0.232 | 0.005 | 0.232 | Dopamine D2 agonist | 0.044 0.031 CID_154699943 | ||
| 0.242 | 0.016 | 0.242 | Alpha 2b adrenoreceptor antagonist | |||
| 0.361 | 0.137 | 0.404 | Caspase 9 stimulant | 0.404 0.109 CID_154699943 | CID_154699943 | |
| 0.226 | 0.004 | 0.226 | Acetylcholine release stimulant | |||
| 0.22 | 0.018 | 0.22 | Antihistaminic | |||
| 0.204 | 0.005 | 0.204 | Dopamine D5 antagonist | |||
| 0.261 | 0.064 | 0.39 | Vasodilator | 0.39 0.025 CID_154699943 | CID_154699943 | |
| 0.202 | 0.007 | 0.202 | Acetylcholine M2 receptor antagonist | |||
| 0.21 | 0.016 | 0.21 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.194 | 0.006 | 0.194 | Histamine N-methyltransferase inhibitor | 0.145 0.016 CID_154699943 | ||
| 0.206 | 0.018 | 0.206 | Histamine antagonist | |||
| 0.244 | 0.059 | 0.244 | Anticonvulsant | 0.142 0.139 CID_154699943 | ||
| 0.187 | 0.005 | 0.187 | Acetylcholine M5 receptor antagonist | |||
| 0.207 | 0.029 | 0.207 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.195 | 0.019 | 0.195 | Alpha 2c adrenoreceptor antagonist | |||
| 0.202 | 0.027 | 0.202 | Neurotrophic factor | 0.116 0.102 CID_154699943 | ||
| 0.21 | 0.037 | 0.21 | Tyrosine-protein kinase receptor antagonist | |||
| 0.244 | 0.074 | 0.244 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.23 0.096 CID_154699943 | ||
| 0.228 | 0.059 | 0.228 | MAP kinase kinase 3 inhibitor | |||
| 0.166 | 0.004 | 0.166 | 5 Hydroxytryptamine 3 agonist | |||
| 0.192 | 0.032 | 0.192 | TRKA antagonist | |||
| 0.176 | 0.018 | 0.176 | Histamine H1 receptor antagonist | |||
| 0.176 | 0.019 | 0.176 | Opioid antagonist | 0.079 0.071 CID_154699943 | ||
| 0.154 | 0.002 | 0.154 | Prolactin release inhibitor | 0.097 0.005 CID_154699943 | ||
| 0.205 | 0.054 | 0.205 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.169 | 0.022 | 0.169 | Protein kinase C gamma inhibitor | |||
| 0.161 | 0.014 | 0.161 | Dopamine D1 antagonist | |||
| 0.166 | 0.019 | 0.166 | Alpha 2a adrenoreceptor antagonist | |||
| 0.248 | 0.104 | 0.248 | Ca(v)3.3 blocker | |||
| 0.15 | 0.009 | 0.15 | TRPA1 antagonist | |||
| 0.146 | 0.005 | 0.146 | Acetylcholine M5 receptor agonist | |||
| 0.164 | 0.023 | 0.164 | Dopamine antagonist | |||
| 0.164 | 0.024 | 0.164 | Alpha 2 adrenoreceptor antagonist | |||
| 0.161 | 0.024 | 0.161 | Antineoplastic alkaloid | 0.101 0.047 CID_154699943 | ||
| 0.146 | 0.011 | 0.146 | Sigma receptor antagonist | |||
| 0.139 | 0.005 | 0.139 | Phosphodiesterase 1A inhibitor | |||
| 0.169 | 0.036 | 0.169 | Nav1.6 sodium channel blocker | |||
| 0.142 | 0.01 | 0.142 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.149 | 0.017 | 0.149 | Phosphodiesterase I inhibitor | 0.097 0.049 CID_154699943 | ||
| 0.135 | 0.004 | 0.135 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.028 CID_154699943 | ||
| 0.136 | 0.006 | 0.136 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.149 | 0.024 | 0.149 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.142 | 0.017 | 0.142 | Analgesic, opioid | 0.069 0.063 CID_154699943 | ||
| 0.152 | 0.028 | 0.152 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.139 | 0.017 | 0.139 | Dopamine D3 antagonist | |||
| 0.183 | 0.062 | 0.183 | Antipruritic | |||
| 0.144 | 0.023 | 0.144 | Dopamine D2 antagonist | |||
| 0.125 | 0.005 | 0.125 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.138 | 0.019 | 0.138 | Dopamine D4 antagonist | |||
| 0.124 | 0.006 | 0.124 | Glutamate (mGluR group I) agonist | |||
| 0.141 | 0.022 | 0.141 | Protein kinase C zeta inhibitor | |||
| 0.139 | 0.021 | 0.139 | Polo-like kinase-1 inhibitor | |||
| 0.123 | 0.005 | 0.123 | Glutamate (mGluR5) agonist | |||
| 0.19 | 0.073 | 0.19 | TRKC antagonist | |||
| 0.15 | 0.034 | 0.15 | Interleukin 8 antagonist | |||
| 0.134 | 0.019 | 0.134 | Alpha adrenoreceptor agonist | |||
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | |||
| 0.161 | 0.048 | 0.161 | Toll-Like receptor antagonist | |||
| 0.245 | 0.131 | 0.481 | Transcription factor NF kappa B inhibitor | 0.481 0.047 CID_154699943 | CID_154699943 | |
| 0.165 | 0.054 | 0.165 | Toll-Like receptor 9 antagonist | |||
| 0.195 | 0.085 | 0.195 | MAP kinase kinase 2 inhibitor | |||
| 0.118 | 0.01 | 0.118 | Alpha 2 adrenoreceptor agonist | |||
| 0.119 | 0.01 | 0.119 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.131 | 0.023 | 0.131 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.13 | 0.022 | 0.13 | Opioid mu receptor antagonist | |||
| 0.125 | 0.018 | 0.125 | Phosphodiesterase XI inhibitor | |||
| 0.125 | 0.018 | 0.125 | Phosphodiesterase 11A inhibitor | |||
| 0.11 | 0.005 | 0.11 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.118 | 0.014 | 0.118 | Acetylcholine M3 receptor antagonist | |||
| 0.109 | 0.007 | 0.109 | Glutamate (mGluR7) antagonist | |||
| 0.111 | 0.009 | 0.111 | Protein kinase C beta inhibitor | 0.108 0.01 CID_154699943 | ||
| 0.147 | 0.049 | 0.147 | TRKB antagonist | |||
| 0.113 | 0.019 | 0.113 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.107 | 0.014 | 0.107 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.095 | 0.005 | 0.095 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.159 | 0.069 | 0.27 | Cytidine deaminase inhibitor | 0.27 0.024 CID_154699943 | CID_154699943 | |
| 0.199 | 0.11 | 0.199 | Tumour necrosis factor alpha release inhibitor | |||
| 0.104 | 0.015 | 0.104 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.144 | 0.055 | 0.144 | Glutamate receptor antagonist | |||
| 0.091 | 0.003 | 0.091 | 5 Hydroxytryptamine 6 agonist | |||
| 0.097 | 0.009 | 0.097 | Histamine agonist | |||
| 0.1 | 0.013 | 0.1 | Orexin receptor 1 antagonist | |||
| 0.191 | 0.104 | 0.191 | Nitric-oxide synthase stimulant | |||
| 0.106 | 0.02 | 0.106 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.115 | 0.029 | 0.115 | Glutamate receptor agonist | |||
| 0.096 | 0.011 | 0.096 | Potassium channel (Tandem pore domain) blocker | |||
| 0.107 | 0.026 | 0.107 | mTOR complex 2 inhibitor | |||
| 0.105 | 0.024 | 0.105 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.094 | 0.015 | 0.094 | Orexin receptor antagonist | |||
| 0.115 | 0.036 | 0.115 | mTOR complex 1 inhibitor | |||
| 0.144 | 0.065 | 0.144 | Pregnane X receptor agonist | |||
| 0.084 | 0.005 | 0.084 | Acetylcholine M4 receptor agonist | |||
| 0.101 | 0.024 | 0.101 | Polo-like kinase-2 inhibitor | |||
| 0.106 | 0.029 | 0.106 | Opioid delta receptor antagonist | |||
| 0.108 | 0.032 | 0.108 | Bromodomain-containing protein 2 inhibitor | |||
| 0.101 | 0.026 | 0.101 | Glutamate (mGluR group I) antagonist | |||
| 0.142 | 0.067 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.129 0.125 CID_154699943 | ||
| 0.11 | 0.036 | 0.11 | Phosphodiesterase 6D inhibitor | |||
| 0.094 | 0.02 | 0.094 | Dopamine uptake inhibitor | |||
| 0.097 | 0.023 | 0.097 | Toll-Like receptor 7 antagonist | |||
| 0.092 | 0.019 | 0.092 | Alpha 1 adrenoreceptor agonist | |||
| 0.167 | 0.094 | 0.167 | MAP kinase kinase 5 inhibitor | |||
| 0.15 | 0.077 | 0.15 | Diuretic | |||
| 0.198 | 0.126 | 0.483 | DNA synthesis inhibitor | 0.483 0.015 CID_154699943 | CID_154699943 | |
| 0.086 | 0.015 | 0.086 | Phosphodiesterase 1C inhibitor | |||
| 0.089 | 0.019 | 0.089 | CDK4/cyclin D1 inhibitor | |||
| 0.074 | 0.005 | 0.074 | Nerve growth factor antagonist | |||
| 0.221 | 0.153 | 0.441 | Antithrombotic | 0.441 0.04 CID_154699943 | CID_154699943 | |
| 0.183 | 0.115 | 0.183 | Aldehyde oxidase inhibitor | |||
| 0.12 | 0.052 | 0.12 | Activin receptor-like kinase 4 inhibitor | |||
| 0.21 | 0.142 | 0.21 | Insulysin inhibitor | |||
| 0.083 | 0.016 | 0.083 | Dopamine transporter inhibitor | |||
| 0.098 | 0.031 | 0.098 | Caspase 7 inhibitor | |||
| 0.081 | 0.014 | 0.081 | Glutamate (mGluR5) antagonist | |||
| 0.086 | 0.019 | 0.086 | Phosphodiesterase 1B inhibitor | |||
| 0.071 | 0.006 | 0.071 | 5 Hydroxytryptamine 1D agonist | |||
| 0.095 | 0.029 | 0.095 | Transforming growth factor beta 3 antagonist | |||
| 0.134 | 0.07 | 0.134 | Death-associated protein kinase 1 inhibitor | |||
| 0.149 | 0.085 | 0.149 | Polo-like kinase-3 inhibitor | |||
| 0.077 | 0.013 | 0.077 | Opioid kappa receptor agonist | |||
| 0.14 | 0.076 | 0.18 | Heat shock protein 70 antagonist | 0.18 0.012 CID_154699943 | CID_154699943 | |
| 0.191 | 0.129 | 0.307 | Interleukin agonist | 0.307 0.045 CID_154699943 | CID_154699943 | |
| 0.076 | 0.014 | 0.076 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.127 | 0.067 | 0.127 | Nav1.3 sodium channel blocker | |||
| 0.103 | 0.043 | 0.103 | Pim-3 kinase inhibitor | |||
| 0.118 | 0.058 | 0.118 | Polo-like kinase-4 inhibitor | |||
| 0.204 | 0.144 | 0.204 | Gastrin inhibitor | |||
| 0.102 | 0.044 | 0.102 | Alpha 2d adrenoreceptor antagonist | |||
| 0.077 | 0.02 | 0.077 | Opioid agonist | |||
| 0.083 | 0.025 | 0.083 | 5 Hydroxytryptamine 2A agonist | |||
| 0.076 | 0.019 | 0.076 | Toll-Like receptor 8 antagonist | |||
| 0.122 | 0.065 | 0.122 | Anesthetic local | |||
| 0.074 | 0.018 | 0.074 | Histamine H3 receptor antagonist | |||
| 0.069 | 0.013 | 0.069 | Histamine H4 receptor antagonist | |||
| 0.078 | 0.023 | 0.078 | CDK4/cyclin D inhibitor | |||
| 0.107 | 0.052 | 0.107 | Alpha adrenoreceptor antagonist | |||
| 0.073 | 0.018 | 0.073 | 5 Hydroxytryptamine 2 agonist | |||
| 0.092 | 0.04 | 0.092 | Glutamate (mGluR) antagonist | |||
| 0.139 | 0.089 | 0.139 | GABA C receptor rho-2 antagonist | |||
| 0.059 | 0.009 | 0.059 | 5 Hydroxytryptamine 2B agonist | |||
| 0.059 | 0.009 | 0.059 | Histamine H1 receptor agonist | |||
| 0.07 | 0.02 | 0.07 | Opioid mu receptor agonist | |||
| 0.069 | 0.02 | 0.069 | 5 Hydroxytryptamine 7 agonist | |||
| 0.076 | 0.027 | 0.076 | Potassium channel Kv1.5 blocker | |||
| 0.057 | 0.008 | 0.057 | Sigma 2 receptor antagonist | |||
| 0.053 | 0.004 | 0.053 | Dopamine D1 agonist | 0.028 0.01 CID_154699943 | ||
| 0.112 | 0.065 | 0.112 | Nav1.5 sodium channel blocker | |||
| 0.074 | 0.027 | 0.074 | 5 Hydroxytryptamine 1 agonist | |||
| 0.107 | 0.06 | 0.107 | GABA C receptor agonist | |||
| 0.069 | 0.022 | 0.069 | mTOR inhibitor | |||
| 0.101 | 0.054 | 0.101 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.18 | 0.134 | 0.2 | DNA damaging | 0.2 0.115 CID_154699943 | CID_154699943 | |
| 0.095 | 0.048 | 0.095 | Acetylcholine M3 receptor agonist | |||
| 0.085 | 0.039 | 0.085 | 5 Hydroxytryptamine agonist | |||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | |||
| 0.054 | 0.008 | 0.054 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.058 | 0.012 | 0.058 | Alpha 1d adrenoreceptor agonist | |||
| 0.056 | 0.011 | 0.056 | Orexin receptor 2 antagonist | |||
| 0.22 | 0.176 | 0.393 | Immunosuppressant | 0.393 0.066 CID_154699943 | CID_154699943 | |
| 0.047 | 0.003 | 0.047 | NMDA receptor phencyclidine site antagonist | |||
| 0.09 | 0.047 | 0.09 | Histamine H2 receptor antagonist | |||
| 0.14 | 0.098 | 0.14 | Heat shock protein 90 alpha antagonist | |||
| 0.106 | 0.064 | 0.106 | Falcipain 3 inhibitor | |||
| 0.148 | 0.107 | 0.148 | Neurotensin receptor agonist | |||
| 0.063 | 0.023 | 0.063 | 5 Hydroxytryptamine 1B agonist | |||
| 0.127 | 0.088 | 0.127 | CDC-like kinase 1 inhibitor | |||
| 0.069 | 0.03 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.098 | 0.059 | 0.098 | Protein kinase C mu inhibitor | |||
| 0.053 | 0.014 | 0.053 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.066 | 0.029 | 0.066 | Fatty acid synthase inhibitor | |||
| 0.08 | 0.045 | 0.08 | Rho-associated kinase II inhibitor | |||
| 0.05 | 0.016 | 0.05 | TRPM8 blocker | |||
| 0.097 | 0.063 | 0.097 | Creatine kinase inhibitor | |||
| 0.058 | 0.025 | 0.058 | Potassium channel (Inward rectifier) blocker | |||
| 0.098 | 0.065 | 0.098 | GABA C receptor rho-1 antagonist | |||
| 0.118 | 0.085 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.079 | 0.047 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.112 | 0.079 | 0.112 | Cyclin-dependent kinase inhibitor | |||
| 0.039 | 0.007 | 0.039 | 5 Hydroxytryptamine 1F agonist | |||
| 0.084 | 0.052 | 0.084 | CC chemokine 5 receptor agonist | |||
| 0.096 | 0.064 | 0.096 | Electrolyte absorption antagonist | |||
| 0.085 | 0.055 | 0.085 | GABA A receptor agonist | |||
| 0.076 | 0.045 | 0.076 | MAP3K7 inhibitor | |||
| 0.072 | 0.042 | 0.072 | CDC7 inhibitor | |||
| 0.091 | 0.061 | 0.091 | Protein kinase C delta inhibitor | |||
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 CID_154699943 | ||
| 0.113 | 0.085 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 CID_154699943 | CID_154699943 | |
| 0.105 | 0.077 | 0.105 | Interleukin 2 antagonist | |||
| 0.037 | 0.01 | 0.037 | DNA topoisomerase IV inhibitor | |||
| 0.063 | 0.037 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.245 | 0.22 | 0.447 | Apoptosis agonist | 0.447 0.093 CID_154699943 | CID_154699943 | |
| 0.104 | 0.078 | 0.104 | Calcium channel (voltage-sensitive) blocker | |||
| 0.107 | 0.082 | 0.107 | Calcium channel N-type blocker | |||
| 0.052 | 0.027 | 0.052 | Dopamine beta hydroxylase inhibitor | |||
| 0.172 | 0.148 | 0.308 | RNA-directed DNA polymerase inhibitor | 0.308 0.03 CID_154699943 | CID_154699943 | |
| 0.074 | 0.05 | 0.074 | Alpha 1b adrenoreceptor antagonist | |||
| 0.057 | 0.033 | 0.057 | Acetylcholine M2 receptor agonist | |||
| 0.086 | 0.062 | 0.086 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.094 | 0.07 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.036 | 0.012 | 0.036 | CDK4/cyclin D3 inhibitor | |||
| 0.061 | 0.039 | 0.061 | Potassium channel (Ca-activated) blocker | |||
| 0.072 | 0.049 | 0.072 | Phospholipase D inhibitor | |||
| 0.057 | 0.035 | 0.057 | Pim-2 kinase inhibitor | |||
| 0.099 | 0.078 | 0.099 | GABA receptor agonist | |||
| 0.037 | 0.016 | 0.037 | Protein kinase (CK2) beta inhibitor | |||
| 0.06 | 0.039 | 0.06 | Cyclin A1 inhibitor | |||
| 0.042 | 0.022 | 0.042 | Vascular adhesion protein 1 inhibitor | |||
| 0.073 | 0.054 | 0.073 | Phosphodiesterase VI inhibitor | |||
| 0.098 | 0.079 | 0.098 | Cystathionine beta-synthase inhibitor | |||
| 0.072 | 0.053 | 0.072 | Rho-associated kinase inhibitor | |||
| 0.136 | 0.118 | 0.136 | Tumour necrosis factor antagonist | |||
| 0.053 | 0.036 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.031 | 0.014 | 0.031 | HCV NS5A inhibitor | |||
| 0.06 | 0.044 | 0.06 | Adrenaline uptake inhibitor | |||
| 0.073 | 0.057 | 0.073 | Alpha 1 adrenoreceptor antagonist | |||
| 0.02 | 0.004 | 0.02 | Cyclin D2 inhibitor | |||
| 0.054 | 0.038 | 0.054 | Lysine-specific demethylase 1A inhibitor | |||
| 0.068 | 0.053 | 0.068 | Benzodiazepine agonist | |||
| 0.067 | 0.052 | 0.067 | Alpha 1a adrenoreceptor antagonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.055 | 0.041 | 0.055 | Bruton tyrosine kinase inhibitor | |||
| 0.087 | 0.075 | 0.087 | Phosphodiesterase 7B inhibitor | |||
| 0.056 | 0.044 | 0.056 | Calcium channel T-type blocker | |||
| 0.053 | 0.041 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.109 | 0.098 | 0.196 | DNA repair enzyme inhibitor | 0.196 0.009 CID_154699943 | CID_154699943 | |
| 0.03 | 0.019 | 0.03 | MAP3K8 inhibitor | |||
| 0.081 | 0.07 | 0.081 | Antiadrenergic | |||
| 0.027 | 0.016 | 0.027 | Calcitonin gene-related peptide antagonist | |||
| 0.109 | 0.099 | 0.109 | Sodium channel (voltage-gated) blocker | |||
| 0.044 | 0.034 | 0.044 | 5 Hydroxytryptamine 1A agonist | |||
| 0.074 | 0.065 | 0.074 | MAP kinase kinase 7 inhibitor | |||
| 0.031 | 0.022 | 0.031 | CXC chemokine 3 receptor antagonist | |||
| 0.028 | 0.018 | 0.028 | Sigma 1 receptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Opioid delta receptor agonist | |||
| 0.038 | 0.029 | 0.038 | Cyclin D3 inhibitor | |||
| 0.033 | 0.025 | 0.033 | CDK6/cyclin D3 inhibitor | |||
| 0.165 | 0.158 | 0.165 | Cardiotonic | |||
| 0.044 | 0.037 | 0.044 | Glycine transporter inhibitor | |||
| 0.065 | 0.058 | 0.065 | CXC chemokine receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.044 | 0.054 | Protein kinase C eta inhibitor | 0.054 0.039 CID_154699943 | CID_154699943 | |
| 0.016 | 0.01 | 0.016 | CXC chemokine 4 receptor agonist | |||
| 0.087 | 0.082 | 0.087 | Insulin receptor antagonist | |||
| 0.037 | 0.031 | 0.037 | MAP3K5 inhibitor | |||
| 0.037 | 0.032 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.075 | 0.071 | 0.075 | Inducible nitric-oxide synthase inhibitor | |||
| 0.025 | 0.021 | 0.025 | Acid ceramidase inhibitor | |||
| 0.071 | 0.067 | 0.071 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.046 | 0.043 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.017 | 0.014 | 0.017 | Histamine H4 receptor agonist | |||
| 0.075 | 0.072 | 0.075 | Adrenaline antagonist | |||
| 0.039 | 0.037 | 0.039 | GABA B receptor antagonist | |||
| 0.051 | 0.048 | 0.051 | Alpha 1d adrenoreceptor antagonist | |||
| 0.055 | 0.052 | 0.055 | Cyclin A2 inhibitor | |||
| 0.041 | 0.039 | 0.041 | Dipeptidyl peptidase IV inhibitor | |||
| 0.243 | 0.242 | 0.243 | MAP kinase 1 inhibitor | |||
| 0.016 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.054 | 0.052 | 0.054 | Glutamate (mGluR) agonist | |||
| 0.037 | 0.039 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 CID_154699943 | CID_154699943 | |
| 0.116 | 0.122 | 0.124 | Hemostatic | 0.124 0.106 CID_154699943 | CID_154699943 | |
| 0.03 | 0.039 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.015 CID_154699943 | CID_154699943 | |
| 0.044 | 0.061 | 0.086 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.086 0.018 CID_154699943 | CID_154699943 | |
| 0.168 | 0.197 | 0.284 | Cholesterol antagonist | 0.284 0.102 CID_154699943 | CID_154699943 | |
| 0.186 | 0.215 | 0.309 | Interleukin 2 agonist | 0.309 0.067 CID_154699943 | CID_154699943 | |
| 0.025 | 0.055 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.029 CID_154699943 | CID_154699943 | |
| 0.172 | 0.21 | 0.459 | Vasodilator, coronary | 0.459 0.022 CID_154699943 | CID_154699943 | |
| 0.021 | 0.06 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_154699943 | CID_154699943 | |
| 0.117 | 0.158 | 0.518 | DNA methylase inhibitor | 0.518 0.005 CID_154699943 | CID_154699943 | |
| 0.076 | 0.126 | 0.203 | Alkylator | 0.203 0.025 CID_154699943 | CID_154699943 | |
| 0.008 | 0.066 | 0.022 | Adenosine kinase inhibitor | 0.022 0.015 CID_154699943 | CID_154699943 | |
| 0.026 | 0.091 | 0.048 | Thymidine kinase inhibitor | 0.048 0.02 CID_154699943 | CID_154699943 | |
| 0.009 | 0.082 | 0.037 | Arginase inhibitor | 0.037 0.025 CID_154699943 | CID_154699943 | |
| 0.028 | 0.122 | 0.086 | Carbamoyl phosphate synthetase inhibitor | 0.086 0.026 CID_154699943 | CID_154699943 | |
| 0.04 | 0.136 | 0.149 | Histone deacetylase SIRT1 stimulant | 0.149 0.009 CID_154699943 | CID_154699943 | |
| 0.04 | 0.136 | 0.149 | Histone deacetylase stimulant | 0.149 0.009 CID_154699943 | CID_154699943 | |
| 0.145 | 0.243 | 0.462 | Immunomodulator | 0.462 0.029 CID_154699943 | CID_154699943 | |
| 0.054 | 0.152 | 0.232 | Expectorant | 0.232 0.015 CID_154699943 | CID_154699943 | |
| 0.005 | 0.111 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_154699943 | CID_154699943 | |
| 0.077 | 0.19 | 0.128 | Protein kinase stimulant | 0.128 0.085 CID_154699943 | CID_154699943 | |
| 0.122 | 0.238 | 0.325 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.325 0.017 CID_154699943 | CID_154699943 | |
| 0.207 | 0.323 | 0.442 | Antiinflammatory | 0.442 0.114 CID_154699943 | CID_154699943 | |
| 0.089 | 0.205 | 0.446 | DNA methyltransferase I inhibitor | 0.446 0.006 CID_154699943 | CID_154699943 | |
| 0.017 | 0.135 | 0.054 | Adenosine deaminase inhibitor | 0.054 0.027 CID_154699943 | CID_154699943 | |
| 0.078 | 0.202 | 0.136 | Cell wall synthesis inhibitor | 0.136 0.08 CID_154699943 | CID_154699943 | |
| 0.013 | 0.14 | 0.082 | Purinergic P2Y antagonist | 0.082 0.012 CID_154699943 | CID_154699943 | |
| 0.08 | 0.217 | 0.156 | Hexokinase inhibitor | 0.156 0.072 CID_154699943 | CID_154699943 | |
| 0.054 | 0.192 | 0.174 | Adenylate cyclase inhibitor | 0.174 0.032 CID_154699943 | CID_154699943 | |
| 0.104 | 0.242 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.084 CID_154699943 | CID_154699943 | |
| 0.083 | 0.224 | 0.204 | Insulin secretagoues | 0.204 0.034 CID_154699943 | CID_154699943 | |
| 0.022 | 0.165 | 0.126 | Biliverdin reductase inhibitor | 0.126 0.013 CID_154699943 | CID_154699943 | |
| 0.026 | 0.173 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.039 CID_154699943 | CID_154699943 | |
| 0.046 | 0.198 | 0.258 | UDP-glucose 4-epimerase inhibitor | 0.258 0.013 CID_154699943 | CID_154699943 | |
| 0.019 | 0.172 | 0.087 | Argininosuccinate synthase inhibitor | 0.087 0.023 CID_154699943 | CID_154699943 | |
| 0.006 | 0.162 | 0.022 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.022 0.006 CID_154699943 | CID_154699943 | |
| 0.049 | 0.207 | 0.127 | NADH dehydrogenase inhibitor | 0.127 0.025 CID_154699943 | CID_154699943 | |
| 0.052 | 0.209 | 0.183 | AMP-activated protein kinase stimulant | 0.183 0.014 CID_154699943 | CID_154699943 | |
| 0.036 | 0.194 | 0.131 | Glutamate dehydrogenase inhibitor | 0.131 0.02 CID_154699943 | CID_154699943 | |
| 0.006 | 0.164 | 0.035 | Purinergic P2X agonist | 0.035 0.015 CID_154699943 | CID_154699943 | |
| 0.088 | 0.247 | 0.396 | Immunostimulant | 0.396 0.051 CID_154699943 | CID_154699943 | |
| 0.009 | 0.171 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 CID_154699943 | CID_154699943 | |
| 0.015 | 0.177 | 0.058 | Adenosine A1 receptor antagonist | 0.058 0.041 CID_154699943 | CID_154699943 | |
| 0.02 | 0.184 | 0.146 | Phosphofructokinase-1 inhibitor | 0.146 0.019 CID_154699943 | CID_154699943 | |
| 0.012 | 0.181 | 0.047 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 CID_154699943 | CID_154699943 | |
| 0.137 | 0.307 | 0.297 | Apoptosis antagonist | 0.297 0.088 CID_154699943 | CID_154699943 | |
| 0.058 | 0.235 | 0.126 | Adenylate kinase inhibitor | 0.126 0.039 CID_154699943 | CID_154699943 | |
| 0.117 | 0.324 | 0.375 | Peptidyltransferase inhibitor | 0.375 0.009 CID_154699943 | CID_154699943 | |
| 0.038 | 0.256 | 0.126 | Uric acid excretion stimulant | 0.126 0.034 CID_154699943 | CID_154699943 | |
| 0.004 | 0.236 | 0.028 | Squalene synthetase inhibitor | 0.028 0.025 CID_154699943 | CID_154699943 | |
| 0.048 | 0.298 | 0.163 | Aldehyde dehydrogenase inhibitor | 0.163 0.04 CID_154699943 | CID_154699943 | |
| 0.038 | 0.29 | 0.125 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.125 0.036 CID_154699943 | CID_154699943 | |
| 0.111 | 0.373 | 0.443 | Antibacterial | 0.443 0.059 CID_154699943 | CID_154699943 | |
| 0.014 | 0.282 | 0.072 | Protein 50S ribosomal subunit inhibitor | 0.072 0.023 CID_154699943 | CID_154699943 | |
| 0.099 | 0.434 | 0.215 | Caspase 3 stimulant | 0.215 0.149 CID_154699943 | CID_154699943 | |
| 0.066 | 0.432 | 0.309 | Hypoglycemic | 0.309 0.05 CID_154699943 | CID_154699943 | |
| 0.034 | 0.401 | 0.351 | Angiogenesis stimulant | 0.351 0.032 CID_154699943 | CID_154699943 | |
| 0.048 | 0.464 | 0.242 | Hepatoprotectant | 0.242 0.046 CID_154699943 | CID_154699943 | |
| 0.016 | 0.437 | 0.244 | Topoisomerase I inhibitor | 0.244 0.018 CID_154699943 | CID_154699943 | |
| 0.031 | 0.482 | 0.204 | Platelet antagonist | 0.204 0.098 CID_154699943 | CID_154699943 | |
| 0.005 | 0.485 | 0.069 | Antineoplastic antibiotic | 0.069 0.066 CID_154699943 | CID_154699943 | |
| 0.004 | 0.495 | 0.022 | Adenosine A3 receptor agonist | 0.022 0.008 CID_154699943 | CID_154699943 | |
| 0.028 | 0.594 | 0.261 | Platelet adhesion inhibitor | 0.261 0.046 CID_154699943 | CID_154699943 | |
| 0.011 | 0.58 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 CID_154699943 | CID_154699943 | |
| 0.005 | 0.575 | 0.066 | Selectin antagonist | 0.066 0.045 CID_154699943 | CID_154699943 | |
| 0.025 | 0.598 | 0.142 | Nitric oxide antagonist | 0.142 0.102 CID_154699943 | CID_154699943 | |
| 0.001 | 0.584 | 0.019 | Purinergic P2 agonist | 0.019 0.007 CID_154699943 | CID_154699943 | |
| 0.001 | 0.584 | 0.019 | Purinergic receptor agonist | 0.019 0.007 CID_154699943 | CID_154699943 | |
| 0.009 | 0.615 | 0.043 | Purinergic P2Y2 antagonist | 0.043 0.014 CID_154699943 | CID_154699943 | |
| 0.022 | 0.641 | 0.232 | DNA polymerase I inhibitor | 0.232 0.02 CID_154699943 | CID_154699943 | |
| 0.001 | 0.629 | 0.014 | Purinergic P2Y agonist | 0.014 0.007 CID_154699943 | CID_154699943 | |
| 0.012 | 0.666 | 0.169 | Free radical scavenger | 0.169 0.125 CID_154699943 | CID_154699943 | |
| 0.003 | 0.672 | 0.041 | Adenosine A1 receptor agonist | 0.041 0.007 CID_154699943 | CID_154699943 | |
| 0.01 | 0.681 | 0.129 | Aminoacyl-tRNA synthetase inhibitor | 0.129 0.026 CID_154699943 | CID_154699943 | |
| 0.027 | 0.748 | 0.495 | Cyclophilin D inhibitor | 0.495 0.052 CID_154699943 | CID_154699943 | |
| 0.011 | 0.733 | 0.192 | Antioxidant | 0.192 0.12 CID_154699943 | CID_154699943 | |
| 0.023 | 0.785 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 CID_154699943 | CID_154699943 | |
| 0.003 | 0.829 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.008 CID_154699943 | CID_154699943 | |
| 0.012 | 0.868 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.016 CID_154699943 | CID_154699943 | |
| 0.002 | 0.88 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.019 0.015 CID_154699943 | CID_154699943 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |